

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 9.00494025 |
| 2 | doxorubicin metabolic process (GO:0044598) | 9.00494025 |
| 3 | daunorubicin metabolic process (GO:0044597) | 9.00494025 |
| 4 | maintenance of protein location in nucleus (GO:0051457) | 6.14253077 |
| 5 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.91022183 |
| 6 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.49291228 |
| 7 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.35956364 |
| 8 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.33450457 |
| 9 | interferon-gamma production (GO:0032609) | 5.31871904 |
| 10 | mannose metabolic process (GO:0006013) | 5.17834594 |
| 11 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.15519751 |
| 12 | regulation of response to osmotic stress (GO:0047484) | 5.12140672 |
| 13 | histone H4-K12 acetylation (GO:0043983) | 5.06126820 |
| 14 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.02826074 |
| 15 | somite rostral/caudal axis specification (GO:0032525) | 5.02665228 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.01332528 |
| 17 | negative regulation of telomerase activity (GO:0051974) | 4.94180936 |
| 18 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.86610268 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.84425726 |
| 20 | histone H4-K5 acetylation (GO:0043981) | 4.83975587 |
| 21 | histone H4-K8 acetylation (GO:0043982) | 4.83975587 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.80345871 |
| 23 | negative regulation of cell killing (GO:0031342) | 4.80345871 |
| 24 | protein localization to kinetochore (GO:0034501) | 4.80325123 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.78352603 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.69015361 |
| 27 | negative regulation of epidermis development (GO:0045683) | 4.68202535 |
| 28 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.54154118 |
| 29 | negative regulation of telomere maintenance (GO:0032205) | 4.39959834 |
| 30 | positive thymic T cell selection (GO:0045059) | 4.39398619 |
| 31 | rRNA transcription (GO:0009303) | 4.38457297 |
| 32 | rRNA methylation (GO:0031167) | 4.36804320 |
| 33 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.34038876 |
| 34 | thymic T cell selection (GO:0045061) | 4.30976178 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.28069877 |
| 36 | rRNA modification (GO:0000154) | 4.17221888 |
| 37 | muscle organ morphogenesis (GO:0048644) | 4.02807005 |
| 38 | negative thymic T cell selection (GO:0045060) | 4.01148646 |
| 39 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.98601495 |
| 40 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.89131827 |
| 41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.88509404 |
| 42 | mitotic sister chromatid segregation (GO:0000070) | 3.84424872 |
| 43 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.84191028 |
| 44 | negative T cell selection (GO:0043383) | 3.82727526 |
| 45 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.79123612 |
| 46 | nucleoside transmembrane transport (GO:1901642) | 3.78386956 |
| 47 | regulation of translation in response to stress (GO:0043555) | 3.78024310 |
| 48 | regulation of gamma-delta T cell activation (GO:0046643) | 3.75988099 |
| 49 | DNA replication checkpoint (GO:0000076) | 3.68301457 |
| 50 | T cell selection (GO:0045058) | 3.67732666 |
| 51 | histone H4-K16 acetylation (GO:0043984) | 3.65089640 |
| 52 | protein localization to chromosome, centromeric region (GO:0071459) | 3.61336331 |
| 53 | cytidine metabolic process (GO:0046087) | 3.55536352 |
| 54 | cytidine catabolic process (GO:0006216) | 3.55536352 |
| 55 | cytidine deamination (GO:0009972) | 3.55536352 |
| 56 | B cell receptor signaling pathway (GO:0050853) | 3.54919119 |
| 57 | regulation of ARF GTPase activity (GO:0032312) | 3.54760036 |
| 58 | positive regulation of protein deacetylation (GO:0090312) | 3.54245201 |
| 59 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.53484590 |
| 60 | positive T cell selection (GO:0043368) | 3.48549268 |
| 61 | intestinal epithelial cell development (GO:0060576) | 3.42959256 |
| 62 | histone H3-K4 methylation (GO:0051568) | 3.42889133 |
| 63 | regulation of telomere maintenance (GO:0032204) | 3.42297484 |
| 64 | tachykinin receptor signaling pathway (GO:0007217) | 3.42227804 |
| 65 | GDP-mannose metabolic process (GO:0019673) | 3.41180669 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.34749007 |
| 67 | nuclear pore complex assembly (GO:0051292) | 3.31884475 |
| 68 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.31688635 |
| 69 | regulation of cilium movement (GO:0003352) | 3.29097145 |
| 70 | leukocyte aggregation (GO:0070486) | 3.28075634 |
| 71 | regulation of histone H3-K27 methylation (GO:0061085) | 3.24701142 |
| 72 | regulation of telomerase activity (GO:0051972) | 3.24628441 |
| 73 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23917819 |
| 74 | response to muramyl dipeptide (GO:0032495) | 3.20877715 |
| 75 | detection of bacterium (GO:0016045) | 3.20484883 |
| 76 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.20046421 |
| 77 | signal complex assembly (GO:0007172) | 3.19580608 |
| 78 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.19038328 |
| 79 | pseudouridine synthesis (GO:0001522) | 3.17428169 |
| 80 | histone H4 deacetylation (GO:0070933) | 3.13164971 |
| 81 | positive regulation of Rap GTPase activity (GO:0032854) | 3.13069049 |
| 82 | pore complex assembly (GO:0046931) | 3.09657578 |
| 83 | sister chromatid segregation (GO:0000819) | 3.07607971 |
| 84 | positive regulation of defense response to virus by host (GO:0002230) | 3.06935667 |
| 85 | germinal center formation (GO:0002467) | 3.06464818 |
| 86 | regulation of ARF protein signal transduction (GO:0032012) | 3.06330067 |
| 87 | heterochromatin organization (GO:0070828) | 3.06295180 |
| 88 | maintenance of protein localization in organelle (GO:0072595) | 3.02770564 |
| 89 | detection of other organism (GO:0098543) | 3.02291007 |
| 90 | ribosome biogenesis (GO:0042254) | 3.00994806 |
| 91 | quinone metabolic process (GO:1901661) | 3.00093018 |
| 92 | negative regulation of cell size (GO:0045792) | 2.99900064 |
| 93 | negative regulation of phagocytosis (GO:0050765) | 2.99483812 |
| 94 | negative regulation of interleukin-2 production (GO:0032703) | 2.96720173 |
| 95 | receptor recycling (GO:0001881) | 2.94480722 |
| 96 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.91999514 |
| 97 | notochord development (GO:0030903) | 2.91902917 |
| 98 | mitochondrion distribution (GO:0048311) | 2.90090000 |
| 99 | phenol-containing compound catabolic process (GO:0019336) | 2.89649639 |
| 100 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.88493667 |
| 101 | NIK/NF-kappaB signaling (GO:0038061) | 2.88474322 |
| 102 | positive regulation of histone deacetylation (GO:0031065) | 2.87872192 |
| 103 | trophectodermal cell differentiation (GO:0001829) | 2.86468064 |
| 104 | chromatin assembly (GO:0031497) | 2.86290562 |
| 105 | regulation of necroptotic process (GO:0060544) | 2.84453470 |
| 106 | histone H3-K4 trimethylation (GO:0080182) | 2.83207354 |
| 107 | nucleoside transport (GO:0015858) | 2.82493654 |
| 108 | positive regulation of B cell differentiation (GO:0045579) | 2.82381934 |
| 109 | tolerance induction (GO:0002507) | 2.80868539 |
| 110 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.80309448 |
| 111 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.80309448 |
| 112 | modulation by symbiont of host immune response (GO:0052553) | 2.80309448 |
| 113 | positive regulation by symbiont of host defense response (GO:0052509) | 2.80309448 |
| 114 | modulation by symbiont of host defense response (GO:0052031) | 2.80309448 |
| 115 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.80309448 |
| 116 | nuclear pore organization (GO:0006999) | 2.80085422 |
| 117 | response to dietary excess (GO:0002021) | 2.79965475 |
| 118 | phospholipid scrambling (GO:0017121) | 2.79792288 |
| 119 | regulation of extracellular matrix disassembly (GO:0010715) | 2.79334448 |
| 120 | negative regulation of myotube differentiation (GO:0010832) | 2.78869634 |
| 121 | retinoic acid receptor signaling pathway (GO:0048384) | 2.77812366 |
| 122 | response to laminar fluid shear stress (GO:0034616) | 2.76709717 |
| 123 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.76236392 |
| 124 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.74837022 |
| 125 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.73491825 |
| 126 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.73491825 |
| 127 | activation of JUN kinase activity (GO:0007257) | 2.70911675 |
| 128 | negative regulation of viral release from host cell (GO:1902187) | 2.70806617 |
| 129 | primitive streak formation (GO:0090009) | 2.70657526 |
| 130 | bone trabecula formation (GO:0060346) | 2.70148549 |
| 131 | histone H3 deacetylation (GO:0070932) | 2.69853368 |
| 132 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.69266646 |
| 133 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.67061108 |
| 134 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.66830618 |
| 135 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.66532866 |
| 136 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.65103689 |
| 137 | modulation by virus of host process (GO:0019054) | 2.64949140 |
| 138 | response to interleukin-15 (GO:0070672) | 2.64415271 |
| 139 | regulation of leukocyte degranulation (GO:0043300) | 2.63547252 |
| 140 | DNA damage response, detection of DNA damage (GO:0042769) | 2.63154148 |
| 141 | phagocytosis, recognition (GO:0006910) | 2.62181345 |
| 142 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61385819 |
| 143 | immunoglobulin mediated immune response (GO:0016064) | 2.61266294 |
| 144 | regulation of B cell differentiation (GO:0045577) | 2.60606920 |
| 145 | positive regulation of developmental pigmentation (GO:0048087) | 2.60600780 |
| 146 | regulation of DNA-dependent DNA replication (GO:0090329) | 2.60340718 |
| 147 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.60330484 |
| 148 | apoptotic DNA fragmentation (GO:0006309) | 2.59100710 |
| 149 | cyclooxygenase pathway (GO:0019371) | 2.57914095 |
| 150 | positive regulation of odontogenesis (GO:0042482) | 2.57602943 |
| 151 | activation of Rac GTPase activity (GO:0032863) | 2.56833679 |
| 152 | negative regulation of bone resorption (GO:0045779) | 2.56771210 |
| 153 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.56359042 |
| 154 | actin filament depolymerization (GO:0030042) | 2.56329886 |
| 155 | DNA duplex unwinding (GO:0032508) | 2.56146420 |
| 156 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.55662016 |
| 157 | regulation of Rap GTPase activity (GO:0032317) | 2.54508266 |
| 158 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.54150304 |
| 159 | mitochondrial DNA replication (GO:0006264) | 2.54003160 |
| 160 | DNA geometric change (GO:0032392) | 2.53808825 |
| 161 | microtubule severing (GO:0051013) | 2.53736543 |
| 162 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.53394637 |
| 163 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.52451803 |
| 164 | B cell homeostasis (GO:0001782) | 2.51665208 |
| 165 | regulation of necrotic cell death (GO:0010939) | 2.51573967 |
| 166 | T cell migration (GO:0072678) | 2.51507698 |
| 167 | hormone catabolic process (GO:0042447) | 2.50568532 |
| 168 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.50431423 |
| 169 | regulation of mast cell degranulation (GO:0043304) | 2.50058487 |
| 170 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.49828098 |
| 171 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.49811844 |
| 172 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.49761092 |
| 173 | establishment of endothelial barrier (GO:0061028) | 2.49307192 |
| 174 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.48506968 |
| 175 | negative regulation of necroptotic process (GO:0060546) | 2.47292081 |
| 176 | response to type I interferon (GO:0034340) | 2.47177610 |
| 177 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.46953781 |
| 178 | semaphorin-plexin signaling pathway (GO:0071526) | 2.45910974 |
| 179 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.44782739 |
| 180 | Peyers patch development (GO:0048541) | 2.44782739 |
| 181 | modulation by symbiont of host cellular process (GO:0044068) | 2.44099937 |
| 182 | regulation of defense response to virus by virus (GO:0050690) | 2.44030641 |
| 183 | type I interferon signaling pathway (GO:0060337) | 2.42757641 |
| 184 | cellular response to type I interferon (GO:0071357) | 2.42757641 |
| 185 | embryonic process involved in female pregnancy (GO:0060136) | 2.41695660 |
| 186 | positive regulation of granulocyte differentiation (GO:0030854) | 2.40094777 |
| 187 | apoptotic process involved in morphogenesis (GO:0060561) | 2.39328280 |
| 188 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.38439788 |
| 189 | histone H3-K36 demethylation (GO:0070544) | 2.36936849 |
| 190 | megakaryocyte development (GO:0035855) | 2.36498261 |
| 191 | T cell receptor signaling pathway (GO:0050852) | 2.35962134 |
| 192 | positive regulation of protein dephosphorylation (GO:0035307) | 2.35675632 |
| 193 | skeletal muscle adaptation (GO:0043501) | 2.34965695 |
| 194 | activated T cell proliferation (GO:0050798) | 2.34025385 |
| 195 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.31872358 |
| 196 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.31711465 |
| 197 | macrophage activation involved in immune response (GO:0002281) | 2.31103889 |
| 198 | creatine metabolic process (GO:0006600) | 2.30705672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.88138021 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.51187648 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.51187648 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.51187648 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 5.11031367 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.03376185 |
| 7 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.45810196 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.39912204 |
| 9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.86210565 |
| 10 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.63245072 |
| 11 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.44316989 |
| 12 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.40707647 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.36979391 |
| 14 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.27659746 |
| 15 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.27509229 |
| 16 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22444927 |
| 17 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.18211586 |
| 18 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.15788977 |
| 19 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.06856093 |
| 20 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.06162928 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.05938348 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.04570797 |
| 23 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.00621651 |
| 24 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.99344932 |
| 25 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.97221258 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95184922 |
| 27 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.93860822 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93020640 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.91743908 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.90348811 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.89866495 |
| 32 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.85758150 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82138088 |
| 34 | MAF_26560356_Chip-Seq_TH2_Human | 1.81712015 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.78626189 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.77811573 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.76744268 |
| 38 | P68_20966046_ChIP-Seq_HELA_Human | 1.68930347 |
| 39 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.68329985 |
| 40 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.67674565 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.66891640 |
| 42 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.66115586 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.62599227 |
| 44 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.62564727 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.62058245 |
| 46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.57562090 |
| 47 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.56578951 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.55897188 |
| 49 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.53537608 |
| 50 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.53337625 |
| 51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.52785293 |
| 52 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.52281114 |
| 53 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.51295827 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48437605 |
| 55 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.46469253 |
| 56 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.45965076 |
| 57 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45379487 |
| 58 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.45080473 |
| 59 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45041676 |
| 60 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.42477073 |
| 61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.42393145 |
| 62 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.42315288 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41027200 |
| 64 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.39824292 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.38822109 |
| 66 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.37696819 |
| 67 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.37462159 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36530490 |
| 69 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.36258604 |
| 70 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36152975 |
| 71 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.35925384 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35165458 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34818953 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34533058 |
| 75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.33462720 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32042145 |
| 77 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31961134 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30365363 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28674860 |
| 80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28653932 |
| 81 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27971032 |
| 82 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.27284183 |
| 83 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26754282 |
| 84 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.26200699 |
| 85 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.25995888 |
| 86 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.25097617 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23615245 |
| 88 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.23434002 |
| 89 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23351583 |
| 90 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.22491798 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21670791 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21542214 |
| 93 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21360322 |
| 94 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21102902 |
| 95 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.20978699 |
| 96 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.20288793 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20280438 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19965433 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19908897 |
| 100 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.18890341 |
| 101 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.18790318 |
| 102 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17823706 |
| 103 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16758338 |
| 104 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16402159 |
| 105 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.16263896 |
| 106 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16070164 |
| 107 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14642029 |
| 108 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14436276 |
| 109 | MYB_26560356_Chip-Seq_TH1_Human | 1.14281011 |
| 110 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.14100867 |
| 111 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.13909402 |
| 112 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10642962 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10489232 |
| 114 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.10382333 |
| 115 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10227824 |
| 116 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.10086992 |
| 117 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09765028 |
| 118 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.09760836 |
| 119 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.09612782 |
| 120 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08178677 |
| 121 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.08063968 |
| 122 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.06898454 |
| 123 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.06771574 |
| 124 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.06549907 |
| 125 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.06487538 |
| 126 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06130655 |
| 127 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05136435 |
| 128 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04591100 |
| 129 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.04106158 |
| 130 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03609446 |
| 131 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03559966 |
| 132 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02732250 |
| 133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02327338 |
| 134 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02026392 |
| 135 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.00572890 |
| 136 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99573832 |
| 137 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.97953672 |
| 138 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.97225498 |
| 139 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.97094386 |
| 140 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95639651 |
| 141 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95422836 |
| 142 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95029160 |
| 143 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94014499 |
| 144 | MYB_26560356_Chip-Seq_TH2_Human | 0.93775184 |
| 145 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.90778660 |
| 146 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.89229630 |
| 147 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.88680224 |
| 148 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.87342442 |
| 149 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.86364506 |
| 150 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.85907344 |
| 151 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85688174 |
| 152 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.84340843 |
| 153 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83806674 |
| 154 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.83723095 |
| 155 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.82737180 |
| 156 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82704410 |
| 157 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.82665232 |
| 158 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82416453 |
| 159 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.81333681 |
| 160 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80570875 |
| 161 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80318224 |
| 162 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.79672027 |
| 163 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.79236007 |
| 164 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.77521402 |
| 165 | MAF_26560356_Chip-Seq_TH1_Human | 0.77226706 |
| 166 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.76986863 |
| 167 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.76644068 |
| 168 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.75904402 |
| 169 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.74850920 |
| 170 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.74823866 |
| 171 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.73732843 |
| 172 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.73181282 |
| 173 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.72188418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006292_abnormal_olfactory_placode | 4.55904568 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 3.84681213 |
| 3 | MP0005075_abnormal_melanosome_morpholog | 3.69862404 |
| 4 | MP0008057_abnormal_DNA_replication | 3.26454055 |
| 5 | MP0005451_abnormal_body_composition | 3.03954256 |
| 6 | MP0002254_reproductive_system_inflammat | 2.99792330 |
| 7 | MP0003011_delayed_dark_adaptation | 2.97051067 |
| 8 | MP0005499_abnormal_olfactory_system | 2.75076939 |
| 9 | MP0005394_taste/olfaction_phenotype | 2.75076939 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.72835795 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.60471507 |
| 12 | MP0003890_abnormal_embryonic-extraembry | 2.46213204 |
| 13 | MP0001873_stomach_inflammation | 2.44328430 |
| 14 | MP0003303_peritoneal_inflammation | 2.43742420 |
| 15 | MP0002277_abnormal_respiratory_mucosa | 2.39657553 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.33149806 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.25375114 |
| 18 | MP0005257_abnormal_intraocular_pressure | 2.19590576 |
| 19 | MP0006082_CNS_inflammation | 2.16072290 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.13761218 |
| 21 | MP0003866_abnormal_defecation | 2.07145590 |
| 22 | MP0002132_abnormal_respiratory_system | 2.04574529 |
| 23 | MP0004858_abnormal_nervous_system | 1.99955300 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.99291904 |
| 25 | MP0003111_abnormal_nucleus_morphology | 1.90299386 |
| 26 | MP0009278_abnormal_bone_marrow | 1.87255331 |
| 27 | MP0002419_abnormal_innate_immunity | 1.83000680 |
| 28 | MP0005671_abnormal_response_to | 1.82969998 |
| 29 | MP0003121_genomic_imprinting | 1.82677762 |
| 30 | MP0004947_skin_inflammation | 1.78891658 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.75952155 |
| 32 | MP0005409_darkened_coat_color | 1.71104223 |
| 33 | MP0000490_abnormal_crypts_of | 1.70275049 |
| 34 | MP0003122_maternal_imprinting | 1.67588131 |
| 35 | MP0005310_abnormal_salivary_gland | 1.66722653 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.66615221 |
| 37 | MP0003724_increased_susceptibility_to | 1.64232295 |
| 38 | MP0003938_abnormal_ear_development | 1.61751649 |
| 39 | MP0003077_abnormal_cell_cycle | 1.58651707 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.58211870 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.57541939 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.54736157 |
| 43 | MP0002822_catalepsy | 1.53282969 |
| 44 | MP0004381_abnormal_hair_follicle | 1.53170978 |
| 45 | MP0005076_abnormal_cell_differentiation | 1.50040964 |
| 46 | MP0003787_abnormal_imprinting | 1.49909255 |
| 47 | MP0009840_abnormal_foam_cell | 1.47411613 |
| 48 | MP0005387_immune_system_phenotype | 1.46766072 |
| 49 | MP0001790_abnormal_immune_system | 1.46766072 |
| 50 | MP0002653_abnormal_ependyma_morphology | 1.44964632 |
| 51 | MP0001800_abnormal_humoral_immune | 1.44149829 |
| 52 | MP0000751_myopathy | 1.43554917 |
| 53 | MP0002933_joint_inflammation | 1.42238886 |
| 54 | MP0005360_urolithiasis | 1.41552771 |
| 55 | MP0001293_anophthalmia | 1.39534707 |
| 56 | MP0005380_embryogenesis_phenotype | 1.38995293 |
| 57 | MP0001672_abnormal_embryogenesis/_devel | 1.38995293 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.37575867 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.36863968 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.36775226 |
| 61 | MP0010094_abnormal_chromosome_stability | 1.32334700 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.29967631 |
| 63 | MP0005666_abnormal_adipose_tissue | 1.27327182 |
| 64 | MP0003984_embryonic_growth_retardation | 1.25548392 |
| 65 | MP0002088_abnormal_embryonic_growth/wei | 1.24350295 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.24237933 |
| 67 | MP0002398_abnormal_bone_marrow | 1.22626512 |
| 68 | MP0001819_abnormal_immune_cell | 1.20165613 |
| 69 | MP0002420_abnormal_adaptive_immunity | 1.20124814 |
| 70 | MP0000350_abnormal_cell_proliferation | 1.19687308 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.18775775 |
| 72 | MP0003763_abnormal_thymus_physiology | 1.18503601 |
| 73 | MP0000716_abnormal_immune_system | 1.17854702 |
| 74 | MP0002452_abnormal_antigen_presenting | 1.17552075 |
| 75 | MP0003091_abnormal_cell_migration | 1.17512350 |
| 76 | MP0002722_abnormal_immune_system | 1.17096836 |
| 77 | MP0008058_abnormal_DNA_repair | 1.16715431 |
| 78 | MP0001663_abnormal_digestive_system | 1.16619341 |
| 79 | MP0000689_abnormal_spleen_morphology | 1.15001364 |
| 80 | MP0003693_abnormal_embryo_hatching | 1.14437665 |
| 81 | MP0008789_abnormal_olfactory_epithelium | 1.13990346 |
| 82 | MP0002405_respiratory_system_inflammati | 1.13255721 |
| 83 | MP0002723_abnormal_immune_serum | 1.12486190 |
| 84 | MP0001845_abnormal_inflammatory_respons | 1.11834809 |
| 85 | MP0003786_premature_aging | 1.09693794 |
| 86 | MP0008007_abnormal_cellular_replicative | 1.09628089 |
| 87 | MP0002092_abnormal_eye_morphology | 1.09442980 |
| 88 | MP0002127_abnormal_cardiovascular_syste | 1.08501803 |
| 89 | MP0008961_abnormal_basal_metabolism | 1.08252505 |
| 90 | MP0002998_abnormal_bone_remodeling | 1.08222646 |
| 91 | MP0002429_abnormal_blood_cell | 1.07384528 |
| 92 | MP0000313_abnormal_cell_death | 1.06443489 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 1.04745402 |
| 94 | MP0000733_abnormal_muscle_development | 1.03887197 |
| 95 | MP0004510_myositis | 1.03789161 |
| 96 | MP0004130_abnormal_muscle_cell | 1.02961659 |
| 97 | MP0003172_abnormal_lysosome_physiology | 1.02575801 |
| 98 | MP0005025_abnormal_response_to | 1.00903225 |
| 99 | MP0000759_abnormal_skeletal_muscle | 0.99672870 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.95957855 |
| 101 | MP0005375_adipose_tissue_phenotype | 0.95924911 |
| 102 | MP0010155_abnormal_intestine_physiology | 0.95420932 |
| 103 | MP0003690_abnormal_glial_cell | 0.94905474 |
| 104 | MP0000747_muscle_weakness | 0.93656872 |
| 105 | MP0001545_abnormal_hematopoietic_system | 0.93567778 |
| 106 | MP0005397_hematopoietic_system_phenotyp | 0.93567778 |
| 107 | MP0003279_aneurysm | 0.93421994 |
| 108 | MP0005166_decreased_susceptibility_to | 0.92410189 |
| 109 | MP0004087_abnormal_muscle_fiber | 0.92363844 |
| 110 | MP0001849_ear_inflammation | 0.90997570 |
| 111 | MP0002932_abnormal_joint_morphology | 0.89959687 |
| 112 | MP0000762_abnormal_tongue_morphology | 0.89618564 |
| 113 | MP0000703_abnormal_thymus_morphology | 0.89367011 |
| 114 | MP0002086_abnormal_extraembryonic_tissu | 0.89045017 |
| 115 | MP0005381_digestive/alimentary_phenotyp | 0.87433813 |
| 116 | MP0006138_congestive_heart_failure | 0.87329193 |
| 117 | MP0003448_altered_tumor_morphology | 0.87048842 |
| 118 | MP0001664_abnormal_digestion | 0.86860618 |
| 119 | MP0002166_altered_tumor_susceptibility | 0.86541879 |
| 120 | MP0001765_abnormal_ion_homeostasis | 0.86098427 |
| 121 | MP0000049_abnormal_middle_ear | 0.85946558 |
| 122 | MP0002114_abnormal_axial_skeleton | 0.84941844 |
| 123 | MP0000003_abnormal_adipose_tissue | 0.84646485 |
| 124 | MP0000685_abnormal_immune_system | 0.84568460 |
| 125 | MP0002085_abnormal_embryonic_tissue | 0.83738632 |
| 126 | MP0008469_abnormal_protein_level | 0.83638852 |
| 127 | MP0000477_abnormal_intestine_morphology | 0.83457513 |
| 128 | MP0003315_abnormal_perineum_morphology | 0.81962466 |
| 129 | MP0001851_eye_inflammation | 0.81488534 |
| 130 | MP0003950_abnormal_plasma_membrane | 0.81211864 |
| 131 | MP0002019_abnormal_tumor_incidence | 0.79353155 |
| 132 | MP0004043_abnormal_pH_regulation | 0.79157893 |
| 133 | MP0003436_decreased_susceptibility_to | 0.78400686 |
| 134 | MP0001348_abnormal_lacrimal_gland | 0.78175218 |
| 135 | MP0000383_abnormal_hair_follicle | 0.78135948 |
| 136 | MP0001958_emphysema | 0.78069229 |
| 137 | MP0002249_abnormal_larynx_morphology | 0.77759771 |
| 138 | MP0000432_abnormal_head_morphology | 0.77563692 |
| 139 | MP0010630_abnormal_cardiac_muscle | 0.77342857 |
| 140 | MP0004036_abnormal_muscle_relaxation | 0.76757603 |
| 141 | MP0009785_altered_susceptibility_to | 0.76579167 |
| 142 | MP0000858_altered_metastatic_potential | 0.76147494 |
| 143 | MP0005391_vision/eye_phenotype | 0.73714029 |
| 144 | MP0008932_abnormal_embryonic_tissue | 0.73232113 |
| 145 | MP0008874_decreased_physiological_sensi | 0.72577307 |
| 146 | MP0009384_cardiac_valve_regurgitation | 0.72196217 |
| 147 | MP0003453_abnormal_keratinocyte_physiol | 0.72144089 |
| 148 | MP0000249_abnormal_blood_vessel | 0.72084055 |
| 149 | MP0002233_abnormal_nose_morphology | 0.70612218 |
| 150 | MP0000428_abnormal_craniofacial_morphol | 0.69885869 |
| 151 | MP0004808_abnormal_hematopoietic_stem | 0.69152932 |
| 152 | MP0002148_abnormal_hypersensitivity_rea | 0.68190624 |
| 153 | MP0003828_pulmonary_edema | 0.68029875 |
| 154 | MP0002098_abnormal_vibrissa_morphology | 0.67027988 |
| 155 | MP0005384_cellular_phenotype | 0.64785724 |
| 156 | MP0004782_abnormal_surfactant_physiolog | 0.64395784 |
| 157 | MP0008260_abnormal_autophagy | 0.64128400 |
| 158 | MP0003136_yellow_coat_color | 0.64096129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 6.04692803 |
| 2 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.84798439 |
| 3 | Hypochromic microcytic anemia (HP:0004840) | 4.78011788 |
| 4 | Chromsome breakage (HP:0040012) | 4.34997313 |
| 5 | Rib fusion (HP:0000902) | 4.28246534 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.19419498 |
| 7 | Hepatoblastoma (HP:0002884) | 4.03998005 |
| 8 | Exercise-induced myalgia (HP:0003738) | 3.84628144 |
| 9 | Multiple enchondromatosis (HP:0005701) | 3.77200032 |
| 10 | Colitis (HP:0002583) | 3.76585386 |
| 11 | Broad face (HP:0000283) | 3.52665457 |
| 12 | Partial duplication of thumb phalanx (HP:0009944) | 3.47251442 |
| 13 | Hypoplasia of the fovea (HP:0007750) | 3.45314281 |
| 14 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.45314281 |
| 15 | Intestinal fistula (HP:0100819) | 3.36700810 |
| 16 | Rectal fistula (HP:0100590) | 3.31704254 |
| 17 | Rectovaginal fistula (HP:0000143) | 3.31704254 |
| 18 | Ependymoma (HP:0002888) | 3.26527958 |
| 19 | Obstructive sleep apnea (HP:0002870) | 3.18992788 |
| 20 | Gastrointestinal inflammation (HP:0004386) | 3.16040502 |
| 21 | Myopathic facies (HP:0002058) | 3.10703872 |
| 22 | Thin bony cortex (HP:0002753) | 3.07608183 |
| 23 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.04965850 |
| 24 | J-shaped sella turcica (HP:0002680) | 3.04832621 |
| 25 | Cheilitis (HP:0100825) | 3.00785610 |
| 26 | Inflammation of the large intestine (HP:0002037) | 2.97483866 |
| 27 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.97359254 |
| 28 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.94838828 |
| 29 | Meckel diverticulum (HP:0002245) | 2.94600180 |
| 30 | Distal lower limb amyotrophy (HP:0008944) | 2.92785700 |
| 31 | Cellulitis (HP:0100658) | 2.91586610 |
| 32 | Testicular atrophy (HP:0000029) | 2.85264273 |
| 33 | Reduced antithrombin III activity (HP:0001976) | 2.85209301 |
| 34 | Partial duplication of the phalanx of hand (HP:0009999) | 2.83435882 |
| 35 | Increased IgE level (HP:0003212) | 2.82510762 |
| 36 | Abnormality of the ileum (HP:0001549) | 2.81739956 |
| 37 | Agammaglobulinemia (HP:0004432) | 2.81056600 |
| 38 | Stridor (HP:0010307) | 2.78083055 |
| 39 | Hemorrhage of the eye (HP:0011885) | 2.76163933 |
| 40 | Abnormality of the salivary glands (HP:0010286) | 2.73633701 |
| 41 | Embryonal renal neoplasm (HP:0011794) | 2.70685478 |
| 42 | Abnormality of the fovea (HP:0000493) | 2.70472968 |
| 43 | Vaginal fistula (HP:0004320) | 2.68645001 |
| 44 | Flat acetabular roof (HP:0003180) | 2.66748627 |
| 45 | Abnormality of the lower motor neuron (HP:0002366) | 2.64888839 |
| 46 | Abnormality of glycolipid metabolism (HP:0010969) | 2.64826276 |
| 47 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.64826276 |
| 48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.64826276 |
| 49 | Increased connective tissue (HP:0009025) | 2.64586409 |
| 50 | Neoplasm of striated muscle (HP:0009728) | 2.63298738 |
| 51 | Impulsivity (HP:0100710) | 2.60421807 |
| 52 | Anomalous pulmonary venous return (HP:0010772) | 2.59247660 |
| 53 | Pustule (HP:0200039) | 2.58872597 |
| 54 | Hypochromic anemia (HP:0001931) | 2.58542627 |
| 55 | Recurrent abscess formation (HP:0002722) | 2.58185654 |
| 56 | Nasolacrimal duct obstruction (HP:0000579) | 2.54574317 |
| 57 | Easy fatigability (HP:0003388) | 2.52726512 |
| 58 | Malnutrition (HP:0004395) | 2.49558977 |
| 59 | Rhabdomyosarcoma (HP:0002859) | 2.49038882 |
| 60 | Recurrent fungal infections (HP:0002841) | 2.46636835 |
| 61 | Gastrointestinal stroma tumor (HP:0100723) | 2.46506834 |
| 62 | Type I transferrin isoform profile (HP:0003642) | 2.46343146 |
| 63 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.46010074 |
| 64 | Villous atrophy (HP:0011473) | 2.46010074 |
| 65 | Recurrent bacterial skin infections (HP:0005406) | 2.44774068 |
| 66 | Distal lower limb muscle weakness (HP:0009053) | 2.44137895 |
| 67 | Abnormal lung lobation (HP:0002101) | 2.42154202 |
| 68 | Duplication of thumb phalanx (HP:0009942) | 2.41918581 |
| 69 | Combined immunodeficiency (HP:0005387) | 2.41141468 |
| 70 | Meningitis (HP:0001287) | 2.41055415 |
| 71 | Abnormality of macrophages (HP:0004311) | 2.40418169 |
| 72 | Spontaneous hematomas (HP:0007420) | 2.39548540 |
| 73 | Cerebral aneurysm (HP:0004944) | 2.39084889 |
| 74 | Fused cervical vertebrae (HP:0002949) | 2.38704555 |
| 75 | Abnormality of the fingertips (HP:0001211) | 2.36670056 |
| 76 | Preauricular pit (HP:0004467) | 2.35045665 |
| 77 | Periauricular skin pits (HP:0100277) | 2.35045665 |
| 78 | Ankle clonus (HP:0011448) | 2.33988879 |
| 79 | Papilledema (HP:0001085) | 2.33278191 |
| 80 | Preauricular skin tag (HP:0000384) | 2.33069438 |
| 81 | Gingivitis (HP:0000230) | 2.29959460 |
| 82 | Obstructive lung disease (HP:0006536) | 2.27327102 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.27327102 |
| 84 | Abnormality of the preputium (HP:0100587) | 2.27314232 |
| 85 | Bifid tongue (HP:0010297) | 2.26719896 |
| 86 | Microvesicular hepatic steatosis (HP:0001414) | 2.23533993 |
| 87 | Small intestinal stenosis (HP:0012848) | 2.22937517 |
| 88 | Duodenal stenosis (HP:0100867) | 2.22937517 |
| 89 | Distal upper limb amyotrophy (HP:0007149) | 2.21002641 |
| 90 | Upper limb amyotrophy (HP:0009129) | 2.21002641 |
| 91 | Dysostosis multiplex (HP:0000943) | 2.20879651 |
| 92 | Abnormality of the astrocytes (HP:0100707) | 2.20474666 |
| 93 | Astrocytoma (HP:0009592) | 2.20474666 |
| 94 | Recurrent viral infections (HP:0004429) | 2.20317330 |
| 95 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.19882401 |
| 96 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.19531607 |
| 97 | Interstitial pulmonary disease (HP:0006530) | 2.18764465 |
| 98 | Prolonged bleeding time (HP:0003010) | 2.17986997 |
| 99 | Emphysema (HP:0002097) | 2.17887488 |
| 100 | Cervical subluxation (HP:0003308) | 2.17540969 |
| 101 | Shawl scrotum (HP:0000049) | 2.15189575 |
| 102 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.14581042 |
| 103 | Trismus (HP:0000211) | 2.13999568 |
| 104 | Bone marrow hypocellularity (HP:0005528) | 2.13914473 |
| 105 | Pendular nystagmus (HP:0012043) | 2.13766827 |
| 106 | Myelodysplasia (HP:0002863) | 2.13292543 |
| 107 | Abnormality of the pulmonary veins (HP:0011718) | 2.12362911 |
| 108 | Nasal polyposis (HP:0100582) | 2.11454341 |
| 109 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.09951111 |
| 110 | Short humerus (HP:0005792) | 2.08990380 |
| 111 | 3-Methylglutaconic aciduria (HP:0003535) | 2.07304684 |
| 112 | Tongue fasciculations (HP:0001308) | 2.06834296 |
| 113 | Skin tags (HP:0010609) | 2.05926219 |
| 114 | Abnormality of chromosome segregation (HP:0002916) | 2.04694928 |
| 115 | Mediastinal lymphadenopathy (HP:0100721) | 2.02278224 |
| 116 | Microretrognathia (HP:0000308) | 2.01480985 |
| 117 | Asymmetric septal hypertrophy (HP:0001670) | 1.97942314 |
| 118 | Verrucae (HP:0200043) | 1.97770665 |
| 119 | Papilloma (HP:0012740) | 1.97770665 |
| 120 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.97691444 |
| 121 | Amyotrophic lateral sclerosis (HP:0007354) | 1.96745482 |
| 122 | Metaphyseal cupping (HP:0003021) | 1.96659710 |
| 123 | EMG: neuropathic changes (HP:0003445) | 1.96274729 |
| 124 | Seborrheic dermatitis (HP:0001051) | 1.95965507 |
| 125 | Gastrointestinal infarctions (HP:0005244) | 1.94889070 |
| 126 | Chest pain (HP:0100749) | 1.94825227 |
| 127 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.94811849 |
| 128 | Large earlobe (HP:0009748) | 1.94742111 |
| 129 | Clubbing of toes (HP:0100760) | 1.94425061 |
| 130 | Ulnar deviation of the wrist (HP:0003049) | 1.94178942 |
| 131 | Lower limb amyotrophy (HP:0007210) | 1.93599599 |
| 132 | Myositis (HP:0100614) | 1.93223814 |
| 133 | Increased variability in muscle fiber diameter (HP:0003557) | 1.93003978 |
| 134 | Aplastic anemia (HP:0001915) | 1.92931539 |
| 135 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.91636393 |
| 136 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.90603428 |
| 137 | Round ear (HP:0100830) | 1.90279949 |
| 138 | Sloping forehead (HP:0000340) | 1.90033451 |
| 139 | Horizontal nystagmus (HP:0000666) | 1.89773152 |
| 140 | Restrictive lung disease (HP:0002091) | 1.89236163 |
| 141 | Muscle fiber inclusion bodies (HP:0100299) | 1.88747753 |
| 142 | Volvulus (HP:0002580) | 1.88550786 |
| 143 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88358347 |
| 144 | Orchitis (HP:0100796) | 1.88303282 |
| 145 | Deformed sella turcica (HP:0002681) | 1.87629560 |
| 146 | Muscle stiffness (HP:0003552) | 1.87459730 |
| 147 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86821004 |
| 148 | Mucopolysacchariduria (HP:0008155) | 1.86821004 |
| 149 | Vasculitis (HP:0002633) | 1.86606872 |
| 150 | Supranuclear gaze palsy (HP:0000605) | 1.86174298 |
| 151 | Spinal canal stenosis (HP:0003416) | 1.85882556 |
| 152 | Growth hormone excess (HP:0000845) | 1.85412120 |
| 153 | Hyperacusis (HP:0010780) | 1.84463785 |
| 154 | Slow saccadic eye movements (HP:0000514) | 1.84265431 |
| 155 | Neuronal loss in central nervous system (HP:0002529) | 1.84050402 |
| 156 | Abnormality of chromosome stability (HP:0003220) | 1.83718247 |
| 157 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.83331652 |
| 158 | Recurrent cutaneous fungal infections (HP:0011370) | 1.83148767 |
| 159 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.83148767 |
| 160 | Abnormality of the thoracic spine (HP:0100711) | 1.82846029 |
| 161 | Abnormality of the lacrimal duct (HP:0011481) | 1.81966862 |
| 162 | Panhypogammaglobulinemia (HP:0003139) | 1.81246684 |
| 163 | Upper limb muscle weakness (HP:0003484) | 1.80696742 |
| 164 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.78998797 |
| 165 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.78361190 |
| 166 | Fatigue (HP:0012378) | 1.78294807 |
| 167 | Supernumerary ribs (HP:0005815) | 1.78114098 |
| 168 | Sensory axonal neuropathy (HP:0003390) | 1.77283450 |
| 169 | Rhabdomyolysis (HP:0003201) | 1.77142267 |
| 170 | Generalized hypotonia (HP:0001290) | 1.76612833 |
| 171 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76408247 |
| 172 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76408247 |
| 173 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76408247 |
| 174 | Onion bulb formation (HP:0003383) | 1.76200829 |
| 175 | Tented upper lip vermilion (HP:0010804) | 1.76183819 |
| 176 | Recurrent skin infections (HP:0001581) | 1.76174576 |
| 177 | Glioma (HP:0009733) | 1.76019037 |
| 178 | Polygenic inheritance (HP:0010982) | 1.75378211 |
| 179 | Difficulty climbing stairs (HP:0003551) | 1.74485974 |
| 180 | Viral hepatitis (HP:0006562) | 1.73905502 |
| 181 | Osteomyelitis (HP:0002754) | 1.73680795 |
| 182 | Thoracic kyphosis (HP:0002942) | 1.73309729 |
| 183 | Nemaline bodies (HP:0003798) | 1.73296709 |
| 184 | Aneurysm (HP:0002617) | 1.72509063 |
| 185 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.72164045 |
| 186 | Annular pancreas (HP:0001734) | 1.71845866 |
| 187 | Skin pits (HP:0100276) | 1.71113044 |
| 188 | Prominent occiput (HP:0000269) | 1.70883594 |
| 189 | Reticulocytosis (HP:0001923) | 1.70033859 |
| 190 | Supernumerary spleens (HP:0009799) | 1.69385581 |
| 191 | Facial cleft (HP:0002006) | 1.69169773 |
| 192 | Muscle fibrillation (HP:0010546) | 1.68765543 |
| 193 | Abnormality of the duodenum (HP:0002246) | 1.67955003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.89194766 |
| 2 | GRK5 | 4.41675787 |
| 3 | GRK6 | 4.20045980 |
| 4 | TRIB3 | 3.96731607 |
| 5 | ADRBK2 | 3.59140268 |
| 6 | GRK1 | 3.52022364 |
| 7 | ERN1 | 3.35255366 |
| 8 | CSF1R | 3.27493661 |
| 9 | PRPF4B | 3.23857053 |
| 10 | RIPK4 | 2.67580971 |
| 11 | SIK1 | 2.65502517 |
| 12 | GRK7 | 2.52755554 |
| 13 | STK10 | 2.36424679 |
| 14 | MAPK7 | 2.35500750 |
| 15 | TGFBR2 | 2.34694651 |
| 16 | MAP2K3 | 2.34229289 |
| 17 | MATK | 2.25719280 |
| 18 | TTK | 2.20461279 |
| 19 | FGFR4 | 1.91515071 |
| 20 | MAP4K1 | 1.89410687 |
| 21 | WNK1 | 1.86784321 |
| 22 | TTN | 1.81658296 |
| 23 | SMG1 | 1.72606975 |
| 24 | EPHA2 | 1.71610288 |
| 25 | RIPK1 | 1.69242173 |
| 26 | EEF2K | 1.67432145 |
| 27 | MAP3K13 | 1.65799098 |
| 28 | CDK7 | 1.61532955 |
| 29 | MST1R | 1.60711086 |
| 30 | PRKG2 | 1.58175463 |
| 31 | ICK | 1.56408042 |
| 32 | AKT3 | 1.52391363 |
| 33 | PKN2 | 1.50781406 |
| 34 | TYRO3 | 1.49561904 |
| 35 | MARK2 | 1.43086412 |
| 36 | BLK | 1.42237674 |
| 37 | CDC42BPA | 1.38752646 |
| 38 | TBK1 | 1.34863282 |
| 39 | CAMK4 | 1.29337459 |
| 40 | PTK6 | 1.27279727 |
| 41 | FES | 1.25792426 |
| 42 | TXK | 1.24011968 |
| 43 | MOS | 1.16935777 |
| 44 | TAOK2 | 1.13993675 |
| 45 | CHEK2 | 1.10929137 |
| 46 | CSK | 1.05017440 |
| 47 | JAK1 | 1.02280940 |
| 48 | HIPK2 | 1.01890155 |
| 49 | MAP3K11 | 1.00661544 |
| 50 | ITK | 0.99872156 |
| 51 | IKBKB | 0.97260743 |
| 52 | CAMKK1 | 0.95936936 |
| 53 | IRAK3 | 0.94848037 |
| 54 | EIF2AK2 | 0.92447743 |
| 55 | MST4 | 0.92013175 |
| 56 | MAP3K6 | 0.91035076 |
| 57 | PAK4 | 0.89759114 |
| 58 | TAOK1 | 0.88991160 |
| 59 | KSR2 | 0.88764570 |
| 60 | PLK1 | 0.88094031 |
| 61 | MAP3K1 | 0.85945384 |
| 62 | NEK2 | 0.85735590 |
| 63 | PDPK1 | 0.84699664 |
| 64 | RPS6KA2 | 0.82594977 |
| 65 | PDGFRA | 0.81935177 |
| 66 | MAPK11 | 0.81906045 |
| 67 | MAP3K7 | 0.80866254 |
| 68 | CHEK1 | 0.80863752 |
| 69 | PDK1 | 0.79559903 |
| 70 | MAP3K3 | 0.79268055 |
| 71 | NTRK1 | 0.78873473 |
| 72 | KIT | 0.78038296 |
| 73 | ALK | 0.76131077 |
| 74 | RET | 0.74155052 |
| 75 | IKBKE | 0.73096157 |
| 76 | PIM2 | 0.71296850 |
| 77 | FGFR3 | 0.70775663 |
| 78 | IRAK4 | 0.69573302 |
| 79 | BMX | 0.69505008 |
| 80 | ADRBK1 | 0.67988159 |
| 81 | JAK3 | 0.65037117 |
| 82 | RPS6KC1 | 0.64370871 |
| 83 | RPS6KL1 | 0.64370871 |
| 84 | CLK1 | 0.62257797 |
| 85 | BUB1 | 0.61267188 |
| 86 | YES1 | 0.57830266 |
| 87 | MAPKAPK3 | 0.57133174 |
| 88 | CHUK | 0.57114925 |
| 89 | SIK2 | 0.56035345 |
| 90 | PRKCI | 0.55659789 |
| 91 | MARK3 | 0.54790868 |
| 92 | ZAP70 | 0.54385749 |
| 93 | MET | 0.53944977 |
| 94 | PIM1 | 0.53292954 |
| 95 | DYRK1B | 0.53168320 |
| 96 | TYK2 | 0.52528076 |
| 97 | LRRK2 | 0.52227480 |
| 98 | JAK2 | 0.52169957 |
| 99 | MAP2K6 | 0.52051904 |
| 100 | AKT2 | 0.50623822 |
| 101 | SYK | 0.50477105 |
| 102 | ZAK | 0.49645622 |
| 103 | LCK | 0.49445193 |
| 104 | HCK | 0.49032495 |
| 105 | MAPK12 | 0.48838018 |
| 106 | PTK2B | 0.46865859 |
| 107 | RPS6KB2 | 0.45619658 |
| 108 | RPS6KA6 | 0.45426146 |
| 109 | FYN | 0.44057440 |
| 110 | PRKCD | 0.43966652 |
| 111 | CDK2 | 0.43522147 |
| 112 | PRKD2 | 0.42194200 |
| 113 | MAP3K2 | 0.41915843 |
| 114 | STK4 | 0.41644414 |
| 115 | WEE1 | 0.41303237 |
| 116 | NME1 | 0.41063510 |
| 117 | MAP2K4 | 0.40918362 |
| 118 | TESK1 | 0.39980482 |
| 119 | PDGFRB | 0.39497258 |
| 120 | BRD4 | 0.39395498 |
| 121 | PRKCH | 0.39330250 |
| 122 | TNK2 | 0.39024615 |
| 123 | TRPM7 | 0.38828643 |
| 124 | OBSCN | 0.38532453 |
| 125 | PRKD1 | 0.38076962 |
| 126 | DDR2 | 0.37966222 |
| 127 | AURKB | 0.37360179 |
| 128 | PRKD3 | 0.37011653 |
| 129 | IGF1R | 0.36459790 |
| 130 | PAK1 | 0.35287272 |
| 131 | PIK3CA | 0.34908975 |
| 132 | MTOR | 0.34630541 |
| 133 | BTK | 0.34579286 |
| 134 | TEC | 0.34443265 |
| 135 | ATM | 0.33433867 |
| 136 | SRPK1 | 0.31360042 |
| 137 | LYN | 0.30354593 |
| 138 | MAP3K14 | 0.30078713 |
| 139 | EPHB1 | 0.29156866 |
| 140 | PKN1 | 0.28489478 |
| 141 | CDK4 | 0.27445448 |
| 142 | NLK | 0.27279944 |
| 143 | ATR | 0.26488005 |
| 144 | STK24 | 0.26073398 |
| 145 | MAPK1 | 0.25653879 |
| 146 | CDK1 | 0.24692079 |
| 147 | STK16 | 0.24363593 |
| 148 | MAPK14 | 0.24202514 |
| 149 | GSK3B | 0.24040561 |
| 150 | MAPKAPK2 | 0.23086558 |
| 151 | MAP2K2 | 0.21738571 |
| 152 | TESK2 | 0.21565704 |
| 153 | SIK3 | 0.20280606 |
| 154 | MKNK2 | 0.20148359 |
| 155 | INSR | 0.19288841 |
| 156 | STK3 | 0.18937196 |
| 157 | MAP3K10 | 0.18647935 |
| 158 | MAPK4 | 0.18274293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.95545340 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.90068407 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.23606507 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.24152048 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.15686828 |
| 6 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.09595171 |
| 7 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.01098905 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.96087677 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 1.82840523 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.65882548 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.63562054 |
| 12 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.63543811 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.61304398 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.57428631 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.56577547 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.53931865 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.52123198 |
| 18 | Galactose metabolism_Homo sapiens_hsa00052 | 1.51849765 |
| 19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.48371688 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.47393082 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.46755447 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.44118049 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.44025615 |
| 24 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.42531489 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.41876446 |
| 26 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.34055850 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33646427 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27519128 |
| 29 | RNA transport_Homo sapiens_hsa03013 | 1.26957227 |
| 30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.22774139 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.21146336 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16070555 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.15070132 |
| 34 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.14381359 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13992953 |
| 36 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.12288677 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11970654 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09150094 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.07625529 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.07555491 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 1.07098266 |
| 42 | RNA degradation_Homo sapiens_hsa03018 | 1.05063487 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04591092 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02826406 |
| 45 | Cell cycle_Homo sapiens_hsa04110 | 1.02586426 |
| 46 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.02365059 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02212151 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97995997 |
| 49 | Spliceosome_Homo sapiens_hsa03040 | 0.97806226 |
| 50 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.96901458 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96698230 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96229101 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94503792 |
| 54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.94437833 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.94225734 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93676151 |
| 57 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93341247 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92480499 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91629783 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 0.91007579 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.90781432 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90349834 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90012193 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89028240 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88735713 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87877203 |
| 67 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.86670140 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.86370339 |
| 69 | Long-term potentiation_Homo sapiens_hsa04720 | 0.85137808 |
| 70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84939538 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.84493353 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.84157318 |
| 73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.84063260 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.83814587 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83794981 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82088925 |
| 77 | Ribosome_Homo sapiens_hsa03010 | 0.81250793 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.80756780 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80602003 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.79962993 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79467144 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78516939 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.78431528 |
| 84 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78012756 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77378199 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76769933 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75075224 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74610936 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72526809 |
| 90 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.72497377 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72345774 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71562587 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.71096615 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68923509 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67547075 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66788483 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65244813 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65223890 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64814231 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64025231 |
| 101 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.62737778 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62021360 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61771898 |
| 104 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.59706653 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59617536 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58811032 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58376727 |
| 108 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58339985 |
| 109 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57471237 |
| 110 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56720202 |
| 111 | Allograft rejection_Homo sapiens_hsa05330 | 0.55370181 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55223279 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54921712 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54884118 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.54680126 |
| 116 | Shigellosis_Homo sapiens_hsa05131 | 0.53635367 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53617700 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53317605 |
| 119 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52768019 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52294353 |
| 121 | Pertussis_Homo sapiens_hsa05133 | 0.52259862 |
| 122 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51964164 |
| 123 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51802920 |
| 124 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.51575046 |
| 125 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51437723 |
| 126 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50003892 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.49611235 |
| 128 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49025089 |
| 129 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46810944 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46478054 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46118405 |
| 132 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.45276098 |
| 133 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44955331 |
| 134 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44894081 |
| 135 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44056613 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43222645 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | 0.43220438 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42324889 |
| 139 | Tuberculosis_Homo sapiens_hsa05152 | 0.41081862 |
| 140 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41039641 |
| 141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40894516 |
| 142 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40020646 |
| 143 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39756913 |
| 144 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39582011 |
| 145 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.39022159 |
| 146 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36941102 |
| 147 | Legionellosis_Homo sapiens_hsa05134 | 0.36910501 |
| 148 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36897982 |
| 149 | Taste transduction_Homo sapiens_hsa04742 | 0.35906271 |

